Connect with others who understand.

sign up log in
Resources
About MyPsoriasisTeam
PSORIASIS
NEWS

FDA Approves Vtama, a Steroid-Free Topical Cream for Psoriasis

Posted on June 21, 2022
Medically reviewed by
Ariel D. Teitel, M.D., M.B.A.
Article written by
Maureen McNulty

  • The U.S. Food and Drug Administration (FDA) has approved a topical cream called Vtama — a formulation of tapinarof — as a treatment for plaque psoriasis.
  • Tapinarof is the first steroid-free topical medication for psoriasis, giving people with the condition access to a new type of treatment option.
  • Clinical trials show that tapinarof works long term and comes with minimal side effects.

The FDA approved a new medication called Vtama this past May for the treatment of plaque psoriasis. Approved for adults with mild, moderate, or severe plaque psoriasis, this is the first new type of topical psoriasis drug to be approved in the United States in 25 years. The cream is applied directly to the skin and can be used anywhere on the body.

Unlike other available topical psoriasis medications, tapinarof is not a steroid. Rather, it’s an aryl hydrocarbon receptor (AhR) agonist — a new type of medication that activates a protein called AhR in order to fight plaque psoriasis on two fronts. In immune cells, AhR turns off genes related to inflammation. In skin cells, it boosts the expression of genes that normalize skin barrier function. Whereas steroids can often only be used in the short term, tapinarof can be used for unlimited periods of time.

Clinical Trial Results

The FDA approval was based on clinical studies that found that tapinarof lessened psoriasis disease severity. Two identical clinical trials, PSOARING 1 and PSOARING 2, reported that 35 percent to 40 percent of study participants were clear or almost clear of psoriasis symptoms after three months of using the drug.

Researchers then conducted another follow-up study called PSOARING 3 to assess the long-term effects of tapinarof. After taking the drug for up to one year, more than 40 percent of study participants experienced a complete clearing of symptoms at some point while on the medication. After the participants stopped using tapinarof, it took an average of four months for symptoms to return.

Study participants reported high levels of satisfaction while using the drug, according to drug manufacturer Dermavent. About 82 percent of participants said they preferred tapinarof to other topical treatments they’d used in the past. Additionally, nearly 86 percent believed that this treatment could help them easily manage their psoriasis, and around 83 percent said they would use tapinarof cream in the future.

Study participants reported some side effects, although these were usually mild or moderate and primarily affected the area of skin in which the cream was applied. According to the FDA, the most common side effects include:

  • Folliculitis (inflammation or infection of the hair follicles, leading to small red or white bumps)
  • Contact dermatitis (a skin rash that is discolored, peeling, itchy, or burning)
  • Itchy skin
  • Nasopharyngitis (swelling or inflammation in the nose or throat)
  • Influenza (the flu)
  • Headache

Dr. Mark Lebwohl, professor at the Icahn School of Medicine at Mount Sinai in New York and one of the researchers leading the tapinarof clinical trials, expressed optimism for the new treatment. “Following 20-plus years of minimal innovation in the topical psoriasis treatment space, I believe the approval of Vtama cream is an important step in establishing a new treatment option for adults with mild, moderate, and severe plaque psoriasis,” Dr. Lebwohl said in a press release. “As a clinician, I’m excited to finally have a versatile, once-daily, steroid-free topical treatment that is backed by extensive clinical trial data supporting its favorable safety and efficacy profile.”

Find Your Team

MyPsoriasisTeam is the social network for people with psoriasis and their loved ones. On MyPsoriasisTeam, more than 108,000 members come together to ask questions, give advice, and share their stories with others who understand life with psoriasis.

What do you think about this new medication? Share your experience in the comments below, or start a conversation by posting on your Activities page.

All updates must be accompanied by text or a picture.
Ariel D. Teitel, M.D., M.B.A. is the clinical associate professor of medicine at the NYU Langone Medical Center in New York. Review provided by VeriMed Healthcare Network. Learn more about him here.
Maureen McNulty studied molecular genetics and English at Ohio State University. Learn more about her here.

Related articles

Treatment for psoriatic arthritis (PsA) can help you reduce painful symptoms and control disease...

Treatments for Psoriatic Arthritis

Treatment for psoriatic arthritis (PsA) can help you reduce painful symptoms and control disease...
Retinoids are often used to treat psoriasis, a skin condition that causes inflammation and leads...

Your Guide to Retinoids for Psoriasis

Retinoids are often used to treat psoriasis, a skin condition that causes inflammation and leads...
If you have psoriasis, you understand the care that goes into selecting the right products for...

Does Coal Tar Help Psoriasis?

If you have psoriasis, you understand the care that goes into selecting the right products for...
Psoriatic arthritis (PsA) primarily causes joint pain and swelling, which can be reduced with...

Treating Psoriatic Arthritis and Skin Symptoms

Psoriatic arthritis (PsA) primarily causes joint pain and swelling, which can be reduced with...
Many people who have been diagnosed with psoriasis, a chronic skin condition that causes dry,...

Can Neem Oil Help Psoriasis?

Many people who have been diagnosed with psoriasis, a chronic skin condition that causes dry,...
Many MyPsoriasisTeam members have looked into home remedies that can ease the symptoms of...

Does Witch Hazel Help Psoriasis?

Many MyPsoriasisTeam members have looked into home remedies that can ease the symptoms of...

Recent articles

Diagnosed with psoriasis in 2010, Vanessa Scott has learned to manage her condition and overcome...

Living With Psoriasis: Managing Flare-ups and Embracing Life

Diagnosed with psoriasis in 2010, Vanessa Scott has learned to manage her condition and overcome...
Nearly 80 percent of people with psoriatic arthritis (PsA) had symptoms of skin psoriasis...

Psoriatic Arthritis Diagnosis and Tests

Nearly 80 percent of people with psoriatic arthritis (PsA) had symptoms of skin psoriasis...
Psoriasis occurs when something goes wrong with your immune system. Your immune cells become...

T Cells in Psoriasis: A Simplified Guide

Psoriasis occurs when something goes wrong with your immune system. Your immune cells become...
The risk for developing psoriasis is associated with many factors, including genetics and...

Psoriasis and Ethnicity: Is Race a Risk Factor?

The risk for developing psoriasis is associated with many factors, including genetics and...
Erythrodermic psoriasis affects an estimated 1 percent to 2.25 percent of people living with...

Erythrodermic Psoriasis: Symptoms and Photos

Erythrodermic psoriasis affects an estimated 1 percent to 2.25 percent of people living with...
Anemia is a common comorbidity (co-occurring condition) in people with psoriasis, psoriatic...

Psoriasis and Anemia: What’s the Connection?

Anemia is a common comorbidity (co-occurring condition) in people with psoriasis, psoriatic...
psoriasis News
psoriasis News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close